Successful treatment of Wegener's granulomatosis associated scleritis with rituximab.
作者信息
Cheung C M G, Murray P I, Savage C O S
出版信息
Br J Ophthalmol. 2005 Nov;89(11):1542. doi: 10.1136/bjo.2005.075689.
Abstract
摘要
相似文献
1
Successful treatment of Wegener's granulomatosis associated scleritis with rituximab.
Br J Ophthalmol. 2005 Nov;89(11):1542. doi: 10.1136/bjo.2005.075689.
2
Rituximab for remission induction in a patient with relapsing necrotizing scleritis associated with limited Wegener's granulomatosis.
Ocul Immunol Inflamm. 2008 Sep-Oct;16(5):230-2. doi: 10.1080/09273940802331643.
3
Regression of necrotizing scleritis in Wegener's granulomatosis after infliximab treatment.
Acta Ophthalmol. 2010 May;88(3):e96-7. doi: 10.1111/j.1755-3768.2009.01546.x. Epub 2009 Sep 16.
4
Anti-TNF alpha therapy in chronic necrotizing scleritis resistant to standard immunomodulatory therapy in a patient with Wegener's granulomatosis.
Eye (Lond). 2005 Sep;19(9):1017-8. doi: 10.1038/sj.eye.6701712.
5
Use of rituximab in Wegener's granulomatosis: comment on the article by Wong.
Nephrol Dial Transplant. 2007 Mar;22(3):958-9; author reply 959. doi: 10.1093/ndt/gfl796. Epub 2007 Jan 20.
6
Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis.
Arthritis Rheum. 2009 May;60(5):1540-7. doi: 10.1002/art.24454.
7
Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab.
Ann Rheum Dis. 2005 Jul;64(7):1087-8. doi: 10.1136/ard.2004.027128.
8
Recurrence of Wegener's granulomatosis with de novo intraoral presentation treated successfully with rituximab.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Jul;108(1):76-80. doi: 10.1016/j.tripleo.2009.02.025. Epub 2009 May 17.
9
Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
Rheumatology (Oxford). 2006 Nov;45(11):1432-6. doi: 10.1093/rheumatology/kel098. Epub 2006 Apr 21.
10
Scleritis--Wegener's granulomatosis.
Insight. 2012 Fall;37(4):13.
引用本文的文献
1
Rituximab in the Treatment of Non-Infectious Uveitis: A Review.
J Inflamm Res. 2024 Sep 29;17:6765-6780. doi: 10.2147/JIR.S477708. eCollection 2024.
2
Efficacy of Rituximab on Refractory Organ Involvements in Granulomatosis with Polyangiitis: A Systematic Review of Case Reports.
Curr Rheumatol Rev. 2024;20(3):270-283. doi: 10.2174/0115733971263964231020072640.
3
Case report peripheral ulcerative keratitis with nodular scleritis, presents as the primary manifestation of granulomatosis with polyangiitis.
Ann Med Surg (Lond). 2023 May 23;85(7):3658-3662. doi: 10.1097/MS9.0000000000000871. eCollection 2023 Jul.
4
The Efficacy and Safety of Rituximab in ANCA-Associated Vasculitis: A Systematic Review.
Biology (Basel). 2022 Dec 6;11(12):1767. doi: 10.3390/biology11121767.
5
A Review of Systemic Biologics and Local Immunosuppressive Medications in Uveitis.
J Ophthalmic Vis Res. 2022 Apr 29;17(2):276-289. doi: 10.18502/jovr.v17i2.10804. eCollection 2022 Apr-Jun.
6
Granulomatosis with polyangiitis presenting with unilateral exophthalmos: A case report.
Radiol Case Rep. 2022 May 28;17(8):2626-2629. doi: 10.1016/j.radcr.2022.03.068. eCollection 2022 Aug.
7
Biologic Therapies and Small Molecules for the Management of Non-Infectious Scleritis: A Narrative Review.
Ophthalmol Ther. 2021 Dec;10(4):777-813. doi: 10.1007/s40123-021-00393-8. Epub 2021 Sep 2.
8
Rituximab for treatment of non-infectious and non-malignant orbital inflammatory disease.
J Ophthalmic Inflamm Infect. 2021 Aug 27;11(1):24. doi: 10.1186/s12348-021-00253-3.
9
Rituximab for non-infectious Uveitis and Scleritis.
J Ophthalmic Inflamm Infect. 2021 Aug 16;11(1):23. doi: 10.1186/s12348-021-00252-4.
10
Commentary: Rituximab in scleritis.
Indian J Ophthalmol. 2020 Sep;68(9):1983-1985. doi: 10.4103/ijo.IJO_896_20.
本文引用的文献
1
Effective therapeutic use of rituximab in refractory Wegener's granulomatosis.
Nephrol Dial Transplant. 2005 Mar;20(3):622-5. doi: 10.1093/ndt/gfh599.
2
Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis.
Arthritis Rheum. 2005 Jan;52(1):262-8. doi: 10.1002/art.20718.
3
The unique antigen receptor signaling phenotype of B-1 cells is influenced by locale but induced by antigen.
J Immunol. 2002 Aug 15;169(4):1735-43. doi: 10.4049/jimmunol.169.4.1735.
4
Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy.
Arthritis Rheum. 2001 Dec;44(12):2836-40. doi: 10.1002/1529-0131(200112)44:12<2836::aid-art471>3.0.co;2-w.
5
Characterization of a human B lymphocyte-specific antigen.
J Immunol. 1980 Oct;125(4):1678-85.
Zotero 插件